The American Lawyer takes a look back at how the plaintiffs’ bar fared for better and for worse in 2016, including a report on the “blockbuster” $14.7 billion settlement in the Volkswagen diesel emissions consumer fraud case that surpassed previous automotive industry records and may well have set an all-time speed and efficiency record for a case of its size, running from inception to resolution in less than a year. [Read more…]
Bloomberg BNA spoke with Lieff Cabraser partner Rachel Geman for a Q&A on upcoming cases involving the Equal Employment Opportunity Commission (EEOC) and anticipated employment law enforcement under President-elect Donald Trump’s incoming administration.
Law360 reviews a list of “Top 5 Multidistrict Litigation Matters,” covering large-scale cases “sure to make headlines in 2017,” all of which include some involvement by Lieff Cabraser. These highly visible multi-district litigation matters include: General Motors Ignition-Switch defects, DePuy Pinnacle Hip injuries, Xarelto (Rivaroxaban) blood thinner injuries, Volkswagen “Clean Diesel” Emissions consumer fraud, and Pelvic Surgical Mesh injuries. [Read more…]
The National Highway Traffic Safety Administration (NHTSA) is investigating a potential Fiat Chrysler auto defect, in which the vehicles roll away despite being shifted into park. U.S. auto safety regulators will be inspecting about 1 million 2013-2016 model year Ram 1500 pickup trucks and 2014-2016 Dodge Durango SUVs in the wake of numerous vehicle roll-away reports. These auto injury reports have included nine injuries and 25 crashes so far. [Read more…]
Stryker Orthopaedics has announced that it has reached a settlement with plaintiffs in both federal multidistrict litigation and New Jersey multicounty litigation over injury claims relating to Rejuvenate and ABG II hip implants. The settlement will compensate eligible U.S. patients who had surgery to replace their hip stems (known as revision surgery) prior to December 19, 2016. [Read more…]
On December 16, 2016, Chief Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida issued an order appointing Lexi J. Hazam of Lieff Cabraser to the Plaintiffs’ Executive Committee in the multidistrict litigation previously consolidated in October 2016 over injuries and financial losses sustained by patients as a result of their use of the prescription drug Abilify. [Read more…]
The American Lawyer (subscription) reports the latest developments in a 20-year “litigation nightmare” that still continues between State Farm Mutual Automobile Insurance Co. and over four million of its policyholders. [Read more…]
A settlement has been reached in the class action digital privacy litigation against Google Inc. regarding claims that the popular Gmail service scanned some outgoing user email messages to build marketing profiles and serve targeted ads. [Read more…]
The Bar Association of San Francisco’s Paralegal Section has announced its 2016 awards, including two Lieff Cabraser staff members. [Read more…]
Bristol-Myers Squibb has agreed to pay $19.5 million to settle claims of improper advertising relating to its top-selling drug Abilify. 42 states and Washington D.C. alleged that the company improperly advertised antipsychotic drug Abilify, first approved in 2002 by the FDA to treat schizophrenic in adults. However, Bristol-Myers Squibb thereafter began promoting Abilify for off-label uses not approved by the FDA. These off-label uses had not been established as safe or effective. [Read more…]
